Prevalence of Major Bleeding in Elderly Patients on Oral Anticoagulants for Non-Valvular Atrial Fibrillation: A Single-Center 12-Year Retrospective Review. [PDF]
Kwan HF +4 more
europepmc +1 more source
Lack of an antagonist to reverse the action of dabigatran [PDF]
Oscar M.P. Jolobe
openalex +1 more source
Post-Ablation Stroke Despite NOAC Use: Successful Reperfusion Therapy After Dabigatran Reversal with Incidental Discovery of a Large MCA Aneurysm-A Case Report. [PDF]
Sari SM +7 more
europepmc +1 more source
The role of ABCB1 and CES1 genotypes on the efficacy and safety of dabigatran: a systematic review and meta-analysis. [PDF]
Aldiban W +9 more
europepmc +1 more source
Conservative Management of Intentional Massive Dabigatran Overdose [PDF]
Nicola Mumoli +5 more
openalex +1 more source
Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial [PDF]
Michael Böhm +11 more
openalex +1 more source
Impact of Different DOACs on Complications of TBI After Low-Energy Trauma. [PDF]
Antoni A +8 more
europepmc +1 more source
Apixaban, edoxaban and rivaroxaban but not dabigatran are associated with higher mortality compared to vitamin‐K antagonists: A retrospective German claims data analysis [PDF]
Christiane Engelbertz +10 more
openalex +1 more source
Impact of direct oral anticoagulants on blood-brain barrier integrity. [PDF]
Sato K +4 more
europepmc +1 more source

